FDA Watchers Divided Between Woodcock, Sharfstein For Agency Chief

President Joe Biden has yet to name a nominee for FDA commissioner, but policy watchers are making their preferences known, with more than 80 health organizations and advocacy groups backing FDA drug center director Janet Woodcock, who is currently serving as acting FDA chief, and 18 scientists, researchers and policy experts saying they want former FDA Principal Deputy Commissioner Joshua Sharfstein in the role. Woodcock has been pegged as a potential front-runner for the full-time commissioner position ever since she...